 Home > Active Ingredient News > Immunology News > Hydroxychloroquine in the eyes of "systemic rheumatoid lupus"

Hydroxychloroquine in the eyes of "systemic rheumatoid lupus"

 Last Update: 2022-08-16
 Source: Internet
 Author: User

Tags

emend drug

roflumilast side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hydroxychloroquine (HCQ), a disease-modifying antirheumatic drug used in the treatment of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), together with methotrexate and sulfasalazine, forms the backbone of triple therapy for .

In SLE, HCQ is recommended as the cornerstone of treatme.

Treatment improves patient survival, reduces disease activity, reduces kidney damage, and reduces the risk of serious comorbidities, including thromboembolic disease and pregnancy complicatio.

The drug is generally safe and can be prescribed to pregnant wom.

Because the new method showed that patients who received lower doses did not experience retinal damage at all when they received higher doses or cumulatively over long periods of ti.

Routine monitoring of HCQ-treated patients using computer-controlled perimeter and OCT methods is now recommended and may help detect retinal toxicity before central vision is affect.

Based on the above, the recommendations for monitoring of patients treated with HCQ have changed :

HCQ is an agent with many beneficial effects in patients with SLE and other connective tissue disorders, and HCQ rarely causes visual impairment in subsequent treatmen.

Prescribing physicians should be aware of national and international drug use guidelines and monitor patients in accordance with these guidelines, but without being subject to undue tightness and unnecessary fe.

Expert Opinion:

references:

Troldborg A, Bay-Laurberg T, Clemmensen K, Andersen J, Deleuran.

Ponticelli C, Moroni.

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.